Published on 13 Mar 2024 on Zacks via Yahoo Finance
It has been about a month since the last earnings report for Immunovant, Inc. (IMVT). Shares have lost about 14.7% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Immunovant, Inc. due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.
Immunovant Q3 Earnings Top Estimates, Pipeline in Focus